ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis
暂无分享,去创建一个
Saurabh Menon | T. Parsons | M. Pantoliano | Saurabh Menon | N. Dales | B. Staker | M. Patane | S. Prasad | Paul Towler | David Williams | Martin Fisher | Martin Fisher | Michael W. Pantoliano | Bart Staker | Sridhar G. Prasad | Jin Tang | Thomas Parsons | Dominic Ryan | Natalie A. Dales | Michael A. Patane | P. Towler | Jin Tang | D. Ryan | David Williams
[1] R. Shapiro,et al. Inhibition of angiotensin converting enzyme: dependence on chloride. , 1984, Biochemistry.
[2] G Bricogne,et al. Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0. , 2003, Acta crystallographica. Section D, Biological crystallography.
[3] Jodie L. Guy,et al. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. , 2003, Biochemistry.
[4] D. Rodgers,et al. Structure of neurolysin reveals a deep channel that limits substrate access , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. McRee. Practical Protein Crystallography , 1993 .
[6] K. Robison,et al. A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 , 2000, Circulation research.
[7] M. Capecchi,et al. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[8] J. Charles Jennette,et al. Malefemale differences in fertility and blood pressure in ACE-deficient mice , 1995, Nature.
[9] Hai-yan Wang,et al. Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys* , 2001, The Journal of Biological Chemistry.
[10] R. Natesh,et al. Crystal structure of the human angiotensin-converting enzyme–lisinopril complex , 2003, Nature.
[11] M. Gerstein,et al. A database of macromolecular motions. , 1998, Nucleic acids research.
[12] W. Bode,et al. Structure of astacin with a transition-state analogue inhibitor , 1996, Nature Structural Biology.
[13] J. Knowles,et al. To build an enzyme.... , 1991, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[14] D. R. Holland,et al. Structural comparison suggests that thermolysin and related neutral proteases undergo hinge-bending motion during catalysis. , 1992, Biochemistry.
[15] N. Rawlings,et al. Evolutionary families of metallopeptidases. , 1995, Methods in enzymology.
[16] J F Riordan,et al. Anion activation of angiotensin converting enzyme: dependence on nature of substrate. , 1983, Biochemistry.
[17] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[18] N. Hooper,et al. The angiotensin-converting enzyme gene family: genomics and pharmacology. , 2002, Trends in pharmacological sciences.
[19] B. Hao,et al. Crystal structure of a novel carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus. , 2002, Structure.
[20] J. Thompson,et al. Using CLUSTAL for multiple sequence alignments. , 1996, Methods in enzymology.
[21] M. A. Wouters,et al. Angiotensin I-converting Enzyme Transition State Stabilization by His1089 , 2001, The Journal of Biological Chemistry.
[22] J. Kraut,et al. How do enzymes work? , 1988, Science.
[23] J F Riordan,et al. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[24] H M Holden,et al. Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues. , 1989, Biochemistry.
[25] J. Inman,et al. A deeply recessed active site in angiotensin-converting enzyme is indicated from the binding characteristics of biotin-spacer-inhibitor reagents. , 1990, Biochemical and biophysical research communications.
[26] M. Crackower,et al. The role of ACE2 in cardiovascular physiology. , 2003, Trends in cardiovascular medicine.
[27] Wolfgang Baumeister,et al. A giant protease with a twist: the TPP II complex from Drosophila studied by electron microscopy , 2002, The EMBO journal.
[28] Nigel M. Hooper,et al. A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.
[29] Affinity chromatographic purification of angiotensin converting enzyme. , 1984, Biochemistry.
[30] S. Teague. Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.
[31] Ook Joon Yoo,et al. Crystal structure of Drosophila angiotensin I‐converting enzyme bound to captopril and lisinopril 1 , 2003, FEBS letters.
[32] P Corvol,et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Dimitrov,et al. The SARS-CoV S glycoprotein: expression and functional characterization , 2003, Biochemical and Biophysical Research Communications.
[34] M. Crackower,et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function , 2002, Nature.
[35] P. Argos,et al. Knowledge‐based protein secondary structure assignment , 1995, Proteins.
[36] D. Tillman,et al. Monoclonal anti-DNA antibodies: structure, specificity, and biology. , 1997, Methods.
[37] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[38] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.
[39] James M. Gavin,et al. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. , 2002, Journal of the American Chemical Society.
[40] U. Eriksson,et al. A story of two ACEs , 2003, Journal of Molecular Medicine.
[41] A. Lesk,et al. Structural mechanisms for domain movements in proteins. , 1994, Biochemistry.
[42] M. A. Wouters,et al. Arg1098 Is Critical for the Chloride Dependence of Human Angiotensin I-converting Enzyme C-domain Catalytic Activity* , 2001, The Journal of Biological Chemistry.
[43] R. Natesh,et al. Deglycosylation, processing and crystallization of human testis angiotensin-converting enzyme. , 2003, The Biochemical journal.
[44] C. A. Stone,et al. A new class of angiotensin-converting enzyme inhibitors , 1980, Nature.
[45] László Polgár,et al. Prolyl Oligopeptidase An Unusual β-Propeller Domain Regulates Proteolysis , 1998, Cell.
[46] J P Abrahams,et al. New developments in phase refinement. , 1998, Current opinion in structural biology.
[47] T. Parsons,et al. Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase* , 2002, The Journal of Biological Chemistry.
[48] Jorge Navaza,et al. [33] AMoRe: An automated molecular replacement program package. , 1997, Methods in enzymology.
[49] Brian W. Matthews,et al. Structural basis of the action of thermolysin and related zinc peptidases , 1988 .
[50] P. R. David,et al. 5 – PROTEIN CRYSTALLOGRAPHY COOKBOOK , 1999 .
[51] A. Berger,et al. On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.